Evidence map›Paper›PMID 42516760›Full record

ArticleBrain communications2026

Identification of a robust multitarget protein panel for Parkinson's disease via absolute quantification and large-scale external replication.

Ho-Won Lee, Youngtae Choi, Shinrye Lee, Jung-Eun Kim, Min-Tae Jeon, Myungjin Jo, Gyuri Park, Jin-Sung Park, Do-Geun Kim, Mookyung Cheon and 1 more

Abstract read
In one paragraph

Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ho-Won LeeDepartment of Neurology, Kyungpook National University Chilgok Hospital, Daegu 41404, Republic of Korea.
Youngtae ChoiDementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41062, Republic of Korea.
Shinrye LeeDementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41062, Republic of Korea.
Jung-Eun KimDepartment of Neurology, Kyungpook National University Chilgok Hospital, Daegu 41404, Republic of Korea.
Min-Tae JeonDementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41062, Republic of Korea.
Myungjin JoDementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41062, Republic of Korea.
Gyuri ParkDementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41062, Republic of Korea.
Jin-Sung ParkDepartment of Neurology, Kyungpook National University Chilgok Hospital, Daegu 41404, Republic of Korea.ORCID https://orcid.org/0000-0001-5506-9206
Do-Geun KimDementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41062, Republic of Korea.
Mookyung CheonDementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41062, Republic of Korea.ORCID https://orcid.org/0000-0001-6777-6725
Hyung-Jun KimDementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41062, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to identify and validate a robust, generalizable panel of plasma protein biomarkers to improve diagnostic precision in Parkinson's disease. We analysed plasma samples from 12 patients with [

Indexed as

interleukin-17CneuroinflammationParkinson’s diseaseplasma biomarkersurokinase plasminogen activator

Identifiers

PMID42516760
PMCPMC13403565

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.